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Delayed healing of skin donor sites may be costly 
and life threatening, especially in patients with large 
body-surface area burns. A donor site dressing 
should maximize the ability of the wound to heal 
without increasing the risk of local infection, sys- 
temic infection, or both. Specibcally, the possibility 
of a secondary infection may either slow the healing 
process or ultimately convert the donor site to a 
full-thickness wound. A number of materials, rang- 
ing from gauze to biological agents, have been in- 
vestigated for use as donor site dressings. The use 
of hydrocolloids for donor sites has been studied 
extensively, and, compared with conventional 
dressings, improved healing rates are reported. Our 
recent study using a hydrocolloid dressing con- 
firmed earlier research showing fewer infections 
and more rapid donor site healing. 
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T he importance of rapid healing in skin graft donor sites is emphasized by the increasing number of 
methods designed to achieve earlier reepithelialization 
[I]; however, other unique concerns are associated with 
the skin graft donor site. In large burns, improved 
healing may allow for faster reharvesting, whereas in 
smaller injuries, hastened epithelialization may result in 
less scarring. Conversely, a secondary infection may 
either slow the healing process or uhimately convert a 
partial skin-thickness donor site to a full skin-thickness 
loss [2]. Thus, size of the donor site, site selection [3], 
skin preparation, graft depth, hemostasis [4], and choice 
of dressing become important considerations. All of 
these issues have a role in the ultimate healing of a skin 
graft donor site and in the incidence of infection. 
DONOR SITE HEALING AND BACTERIA 
Where healthy tissue exists and bacterial populations 
are noninvasive, wound healing proceeds in a normal 
fashion [S-7]. In these cases, bacterial populations may 
stimulate the inflammatory response that initiates wound 
healing [B-9]. Histologically observed invasion of viable 
tissue by pathogenic organisms distinguishes invasive 
wound sepsis from colonization [6]. Noninvasive bacte- 
rial populations may remain over the surface of the 
wound without impairing healing below [5]. The critical 
factor in wound healing appears to be the bacterial 
population in the wound, as opposed to the population 
over the surface of the wound. 
Bacterial populations vary over different parts of the 
body [IO]. This fact, plus concern for final cosmetic 
result, may influence donor site selection [3]. Prepara- 
tion of the donor site area before harvest, as well as 
careful attention to hemostasis and clot removal from 
the bed after harvest, may be important for the control 
of microbial populations [4]. Depth of the donor area 
not only affects scar formation, but may also have a role 
in the incidence of infection [3]. As the depth of the 
wound increases, healing is slowed, and the wound 
becomes more susceptible to bacterial contamination as 
the time to healing is prolonged. When colonization of 
the wound occurs, there may be enhancement of the 
initial inflammatory response caused by skin harvest. If 
this inflammatory response persists, the ensuing patho- 
logic finding of edema and mediator-induced necrosis 
may predispose the underlying tissue to invasion. 
Early after harvest, the inflammatory response in the 
surrounding tissue may mask the inflammatory response 
associated with bacterial colonization. Hunt [ZZ] showed 
the cascade of inflammatory events associated with 
normal wound healing; however, the inflammatory re- 
sponse compounded by microorganisms may be severe 
and lead to destruction of adjacent tissue [I2]. Necrosis 
of tissue assists microbial invasion and conversion of the 
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Figure 1. Infection rates for donor sites dressed with a conven- 
tional or occlusive dressing. (Adapted with permission from [ 791.) 
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skin graft donor site to a full skin-thickness injury with a 
reported incidence of infection as high as 25% [2,13,14]. 
DONOR SITE DRESSINGS AND INFECTION 
Figure 2. Mean healing time, paired donor sites in 12 patients 
treated with silver sulfadiazine cream alone (0) or silver sulfadia- 
zine cream containing epidermal growth factor (0). (Reprinted 
with permission from [23].) 
A donor site dressing should maximize the ahiiity of 
the wound to heal without increasing the risk of local or 
systemic infection. Donor site dressings are divided into 
several categories: open, semi-open, semi-occlusive, and 
occlusive. As early as 1962, Winter [15] showed that 
moist wounds healed faster than wounds left to dry out. 
This observation has led the care of skin graft donor sites 
away from the conventional dry gauze dressings toward 
the semi-occlusive or occlusive dressings. Although these 
occlusive dressings provide moist environments for 
wound healing, there has been concern that occlusion of 
wounds would lead to increased infection [16-181. How- 
ever, Hutchinson and McGuckin [19], in a review of 29 
donor site studies, showed an infection rate of only 2.7% 
in 594 occluded wounds versus an infection rate of 6.4% 
in 360 conventionally dressed wounds (Figure 1). In a 
recent study on donor site wound healing, 30 bum 
patients with skin graft donor sites were randomized to 
receive either an occlusive (DuoDERM CGF, Conva- 
Tee, Skillman, NJ) or conventional gauze dressing on 
their wounds [2]. Wounds in both groups were colonized 
with bacteria; however, only conventionally dressed 
wounds became infected (Table I). Bacteria were pre- 
sent intraoperatively in 9 of 14 (64%) hydrocolloid- 
treated sites and in 5 of 16 (31%) conventionally treated 
sites. At the first dressing change, positive cultures were 
obtained from 4 of 12 (33%) of the hydrocolloid dressed 
wounds and from 6 of 7 (86%) of the conventionally 
dressed wounds. Infection was determined by organism 
recovered and by the established classic clinical signs 
[20]. The conventionally dressed wounds had a 25% 
infection rate caused by Staphylococcus, Pseudomonas, 
and Candida. In this patient population, colonization of 
the wound under the hydrocolloid dressing did not lead 
to infection. 
DONOR SITE HEALING AND THE WOUND 
ENVIRONMENT 
Figure 3. Reported time to healing skin graft donor sites. From 
12,231. 
Hydrocolloid dressings provide a unique wound heal- 
ing environment for the epithelialization of skin graft 
donor sites while decreasing the rate of wound infection. 
Normal wound healing is a series of orchestrated events 
with an initiation phase, collagen deposition phase, 
keratinocyte ingrowth phase, and maturation phase. The 
process is dependent on oxygen delivery to tissue, pH of 
tissue, and development of a local wound environment 
conducive to the cells involved in repair. Growth factors 
provided exogenously or by repairing cells have been the 
focal point of numerous wound healing investigations 
[21-231. Brown and associates [23] investigated epider- 
ma1 growth factor (EGF) in association with skin graft 
donor site healing. This work showed that EGF de- 
creased the time to healing to 7-17 days (mean: 10.9 
days) compared with 9-21 days (mean: 12.3 days) for 
control donor sites (Figure 2). 
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TABLE I 
Incidence of Donor Site Colonization and Infection 
Percentage of Wounds Colonized 






Conventional 31 86 25 
Hydrocolloid 64 33 0 
” = 30. 
From [Z]. 
I 
Although the mechanism of wound healing promo- 
tion by hydrocolloids is unknown, Madden et al [14] 
showed that exudates from wounds occluded with a 
hydrocolloid dressing promoted keratinocyte prolifera- 
tion. When the results of Smith et al [2] are compared 
with those of Brown et al [23], it appears that both the 
hydrocolloid dressing studied and EGF support the 
early stages of wound healing in a similar fashion (Figure 
3). However, in the mid-stage of reepithelialization, the 
hydrocolloid dressing appeared superior to both EGF 
and control treatment. These data suggest that hydrocol- 
loids provide a similar rate of wound healing to that of 
EGF. This comparison of data is based on the assump- 
tion that the donor sites in the two studies were of 
similar size and depth. 
In summary, the search for an ideal donor site 
dressing continues. Improvements in healing and infec- 
tion rates remain important considerations. Currently, 
some hydrocolloid dressings appear to possess many of 
the benefits for the designation of the ideal donor site 
dressing. 
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DISCUSSION 
M. Kerstein: Do you have any problem with un- 
wanted dressing adherence? 
D. Smith: Yes, they are not always easy to keep on 
the lower back or buttocks or on circumferential donor 
sites. For the latter, I cannot recommend the hydrocol- 
loid because I do not know how to keep it there. For 
those, I use a semi-occlusive dressing, fine mesh gauze, 
or silver sulfadiazine. A dry dressing, whether it is 
parachute silk or just plain gauze, is probably the worst 
way to heal a wound. 
C. Burton: Would you agree that occlusion is the 
right thing for donor sites? 
D. Smith: Yes, based on these criteria: less pain, 
faster healing, less infection, and simple patient accep- 
tance. 
C. Burton: What is the time between dressing 
changes? 
D. Smith: From 2-5 days. 
M. Kerstein: What is the normal infection rate for 
donor sites? 
D. Smith: The local infection rate, not for systemic 
infections, reported for conventionally dressed donor 
sites is 525%. 
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